|
Terminated
|
NCT01863381 -
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement
|
N/A |
|
Recruiting
|
NCT06027567 -
The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure
|
Phase 4 |
|
Active, not recruiting
|
NCT02896452 -
Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome
|
|
|
Not yet recruiting
|
NCT06059703 -
Biomarkers in the Etiology of Idiopathic Intracranial Hypertension
|
N/A |
|
Terminated
|
NCT05347147 -
A Trial to Determine the Efficacy and Safety of Presendin in IIH
|
Phase 3 |
|
Not yet recruiting
|
NCT06361823 -
Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
|
Phase 3 |
|
Active, not recruiting
|
NCT02124486 -
An RCT of Bariatric Surgery vs a Community Weight Loss Programme for the Sustained Treatment of IIH
|
N/A |
|
Recruiting
|
NCT02143258 -
Stenting of Venous Sinus Stenosis for Medically Refractory Idiopathic Intracranial Hypertension
|
N/A |
|
Not yet recruiting
|
NCT05762367 -
MR Lymphatic Imaging in Idiopathic Intracranial Hypertention
|
N/A |
|
Completed
|
NCT03867461 -
The Effects of MAP and EtCO2 on Venous Sinus Pressures
|
N/A |
|
Completed
|
NCT03963336 -
Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension
|
Early Phase 1 |
|
Completed
|
NCT01003639 -
Idiopathic Intracranial Hypertension Treatment Trial
|
Phase 2/Phase 3 |
|
Recruiting
|
NCT03096743 -
Evaluating Raised Intracranial Pressure Using MR Elastography
|
N/A |
|
Completed
|
NCT04314128 -
Assessment of ICP in Idiopathic Intracranial Hypertension Using Transocular Ultrasound and Transcranial Doppler
|
N/A |
|
Terminated
|
NCT03501966 -
Surgical Idiopathic Intracranial Hypertension Treatment Trial
|
Phase 3 |
|
Active, not recruiting
|
NCT03556085 -
Venous Sinus Stenting With the River Stent in IIH
|
N/A |
|
Completed
|
NCT02017444 -
Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.
|
Phase 2 |